ACA
SYRE icon

Avoro Capital Advisors’s Spyre Therapeutics SYRE Stock Holding History

Avoro Capital Advisors’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-598,600
Closed -$17.6M – 44
2024
Q3 		$17.6M Sell
598,600
-1,240,538
-67% -$34.5M 0.26% 33
2024
Q2 		$43.2M Hold
1,839,138
– – 0.58% 29
2024
Q1 		$69.8M Hold
1,839,138
– – 0.81% 26
2023
Q4 		$39.6M Buy
1,839,138
+1,827,680
+15,951% +$25.2M 0.55% 25
2023
Q3 		$140K Hold
11,458
– – ﹤0.01% 46
2023
Q2 		$129K Buy
+11,458
New +$54.3K ﹤0.01% 43

Other funds holding SYRE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return